Moraga Biotechnology Corporation,
an adult stem cell company based in Los Angeles, California, announces the
discovery of its proprietary Blastomere-Like Stem Cells (BLSCs) circulating
in the peripheral blood of mammals. The Company's scientists found that
these adult stem cells were able to differentiate into most tissues and
organs of the body.
The Company's scientists have developed a proprietary and
cost-effective method for isolating and purifying large numbers of its
primitive embryonic- like stem cells from the blood without ex vivo
expansion. Moraga recently announced that its BLSCs were found in large
numbers throughout the body. The Company believes this new discovery is a
major breakthrough for finding large numbers of primitive adult stem cells
circulating in the blood.
Moraga's chief executive, Dr. John F. Wong, noted that the ability to
isolate these primitive embryonic-like stem cells in peripheral blood
allows the Company to enter the stem cell banking business in the near
future. With this new method for isolating stem cells, the Company will be
able to bank an individual's stem cells by simply withdrawing a sample of
their blood. The Company intends in the very near future to establish
processing centers to which a donor's blood sample is shipped; the blood is
processed; and, the stem cells are isolated. The BLSCs are then stored at
the center for future therapeutic and diagnostic use. Dr. Wong further
stated that "by circumventing the expensive process of isolating and
expanding the stem cells outside the body, the Company can now travel down
a shorter path towards developing a near-term solution for autologous stem
cell-based therapies, from which its BLSCs may be used for treating various
forms of diseases such as heart attacks, Parkinson's disease and stroke."
Moraga Biotechnology Corporation
moragabiotech
Комментариев нет:
Отправить комментарий